| Mrs Andrea Renee Hannon, RN | |
|
920 Essington Rd, Joliet, IL 60435-2859 | |
| (815) 744-4770 | |
| (815) 744-4772 |
| Full Name | Mrs Andrea Renee Hannon |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 920 Essington Rd, Joliet, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093018319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 041366787 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Andrea Renee Hannon, RN 920 Essington Rd, Joliet, IL 60435-2859 Ph: (815) 744-4770 | Mrs Andrea Renee Hannon, RN 920 Essington Rd, Joliet, IL 60435-2859 Ph: (815) 744-4770 |
News Archive
Researchers based at the Rice University, Texas, USA, have now demonstrated a novel method of predicting a species' susceptibility to contracting COVID-19, based on the animal's structure of ACE2.
4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that initial safety and efficacy data from its ongoing Phase II Study with resminostat, a pan-Histone Deacetylase (HDAC) Inhibitor, in relapsed/refractory Hodgkin Lymphoma (HL) patients after high dose chemotherapy and autologous hematopoietic stem cell transplantation will be presented at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, USA.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the Phase 2 cohort of the MD Anderson Cancer Center-sponsored Phase 1/2 study of quizartinib in combination with either 5-azacitidine or low dose cytarabine for previously untreated FLT3-ITD positive acute myeloid leukemia (AML) patients age 60 or older, or FLT3-ITD positive AML patients 18 years of age or older in first relapse.
Scientists are mapping the habits of cancer cells, turn by microscopic turn. Using advanced technology and an approach that merges engineering and medicine, a Yale University-led team has compiled some of the most sophisticated data yet on the elaborate signaling networks directing highly invasive cancer cells. Think of it as a digital field guide for a deadly scourge.
› Verified 7 days ago
Kristine C Kim, CRNA Registered Nurse Medicare: Medicare Enrolled Practice Location: 333 Madison St, Joliet, IL 60435 Phone: 815-725-7133 | |
Michela Kwak, Registered Nurse Medicare: Medicare Enrolled Practice Location: 333 Madison St, Joliet, IL 60435 Phone: 815-725-7133 | |
Micquette Danielle Brown, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1910 Maserati Dr, Joliet, IL 60435 Phone: 815-207-1725 | |
Elizabeth Dillman-jancek, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2000 Glenwood Ave, Joliet, IL 60435 Phone: 708-202-8387 | |
Richard Ryan Zuniga, CRNA Registered Nurse Medicare: Medicare Enrolled Practice Location: 333 Madison St, Joliet, IL 60435 Phone: 815-725-7133 | |
Dr. Bianca Pruitt, RN,MSN,DNP,CCM Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 129 Edison Rd, Joliet, IL 60433 Phone: 815-651-4315 |